— Know what they know.
Not Investment Advice

HKPD NASDAQ

Cellyan Biotechnology Co., Ltd
1W: -3.5% 1M: -20.9% 3M: -17.9% YTD: -31.8% 1Y: -48.1%
$0.53
-0.02 (-3.64%)
 
Weekly Expected Move ±11.1%
$0 $0 $1 $1 $1
NASDAQ · Healthcare · Medical - Pharmaceuticals · Alpha Radar Sell · Power 38 · $5.8M mcap · 3M float · 3.98% daily turnover · Short 18% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$5.8M
52W Range0.37-2.76
Volume12,268
Avg Volume127,673
Beta2.63
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOChenyu Liang
Employees27
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2025-01-15
Website9zt.hk
Well Town Industrial Building
Yau Tong 999077
HK
852 2618-9289
About Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms